4.43 USD
↗ 0.10 (2.36%)LIVE (AS OF 10:19 AM EDT)
Corbus Pharmaceuticals Holdings, Inc.
CRBPNASDAQ • USD
Market: OPEN
Shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) are trading at $4.43. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest CRBP is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 15, 2026.
Open?$4.35
High?$4.79
Low?$4.24
Prev. Close?$4.33
Volume?118.6K
Avg. Volume?1.2M
VWAP?$4.33
Rel. Volume?0.10x
Bid / Ask
Bid?$4.35 × 100
Ask?$4.39 × 100
Spread?$0.04
Midpoint?$4.37
Valuation & Ratios
Market Cap?83.7M
Shares Out?18.7M
Float?16.2M
Float %?87.0%
P/E Ratio?N/A
P/B Ratio?0.82
EPS?-$5.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Themes
Employees
36
Market Cap
85.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-10-24
Address
500 RIVER RIDGE DRIVE
NORWOOD, MA 02062
Phone: 617-963-0103
NORWOOD, MA 02062
Phone: 617-963-0103
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?26
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.55Distress
Confidence?54%Low
Short InterestHigh
Short % of Float?18.80%High
Short Interest?3.1M
Days to Cover?3.9
Free Float16.2M
Avg Daily Volume791.4K
Settlement Date2026-09-30
Financial Health
Current Ratio?5.71Strong
Quick Ratio?5.71Strong
Cash Ratio?1.09Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.82CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-99.7%WEAK▾
S&P3
ROA?-80.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-86687000
Enterprise Value?$60.4M
Fundamentals ratios updated end of day